TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Takara L Stanley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.